News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
ActivBiotics Cuts IPO Price To $8-$10 Per Share
November 9, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Nov 9 (Reuters) - ActivBiotics Inc. on Thursday cut the expected price of its planned initial public offering to between $8 and $10 per share from a previous range of $12 to $14.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPO tracker
Parabilis follows hefty Regeneron deal with IPO push
May 20, 2026
·
13 min read
·
Editorial Team
Deals
Regeneron, Parabilis set out to create new drug class in deal worth up to $2.3B
May 18, 2026
·
2 min read
·
Gabrielle Masson
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Hiring outlook: job opportunities on
BioSpace
rise YOY, but layoffs affect thousands
May 14, 2026
·
3 min read
·
Angela Gabriel